Karin Quanz

883 total citations
14 papers, 589 citations indexed

About

Karin Quanz is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Karin Quanz has authored 14 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 5 papers in Molecular Biology. Recurrent topics in Karin Quanz's work include Nitric Oxide and Endothelin Effects (6 papers), Pulmonary Hypertension Research and Treatments (5 papers) and Neuroscience of respiration and sleep (5 papers). Karin Quanz is often cited by papers focused on Nitric Oxide and Endothelin Effects (6 papers), Pulmonary Hypertension Research and Treatments (5 papers) and Neuroscience of respiration and sleep (5 papers). Karin Quanz collaborates with scholars based in Germany, Switzerland and France. Karin Quanz's co-authors include Norbert Weißmann, Werner Seeger, Ralph T. Schermuly, Friedrich Grimminger, Hossein Ardeschir Ghofrani, Ludger Fink, Andreas Günther, Clemens Ruppert, Leander Ermert and Philipp Markart and has published in prestigious journals such as Journal of the American College of Cardiology, Circulation Research and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Karin Quanz

14 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karin Quanz Germany	11	340	203	168	110	106	14	589
Al Haromy Canada	8	285 0.8×	203 1.0×	249 1.5×	181 1.6×	117 1.1×	8	668
Galina Filippov United States	11	237 0.7×	406 2.0×	260 1.5×	213 1.9×	81 0.8×	13	677
Yoshiteru Morio Japan	16	544 1.6×	353 1.7×	265 1.6×	197 1.8×	119 1.1×	41	940
Lyubov Czech United States	11	531 1.6×	156 0.8×	182 1.1×	94 0.9×	91 0.9×	14	693
Sadafumi Ono Japan	9	247 0.7×	90 0.4×	104 0.6×	69 0.6×	60 0.6×	22	434
Martin N. Hicks United Kingdom	11	291 0.9×	128 0.6×	189 1.1×	322 2.9×	30 0.3×	28	605
Melody A. Farrar United States	9	195 0.6×	159 0.8×	61 0.4×	79 0.7×	77 0.7×	9	386
Malcolm Robb Canada	11	284 0.8×	92 0.5×	253 1.5×	107 1.0×	36 0.3×	12	661
Natalie R. Bauer United States	5	363 1.1×	251 1.2×	211 1.3×	145 1.3×	55 0.5×	7	537
Guillaume Gary‐Bobo France	9	320 0.9×	187 0.9×	333 2.0×	137 1.2×	21 0.2×	12	758

Countries citing papers authored by Karin Quanz

Since Specialization

Citations

This map shows the geographic impact of Karin Quanz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Quanz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Quanz more than expected).

Fields of papers citing papers by Karin Quanz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Quanz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Quanz. The network helps show where Karin Quanz may publish in the future.

Co-authorship network of co-authors of Karin Quanz

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Quanz. A scholar is included among the top collaborators of Karin Quanz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Quanz. Karin Quanz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Knoepp, Fenja, Shariq Abid, Amal Houssaïni, et al.. (2025). Piezo1 in PASMCs: Critical for Hypoxia-Induced Pulmonary Hypertension Development. Circulation Research. 136(9). 1031–1048. 4 indexed citations

Quanz, Karin, Aleksandar Petrovic, Clemens Ruppert, et al.. (2024). The diverging roles of insulin-like growth factor binding proteins in pulmonary arterial hypertension. Vascular Pharmacology. 155. 107379–107379. 3 indexed citations

Veith, Christine, Simone Kraut, J Wilhelm, et al.. (2016). NADPH Oxidase 4 is Not Involved in Hypoxia‐Induced Pulmonary Hypertension. Pulmonary Circulation. 6(3). 397–400. 30 indexed citations

Schermuly, Ralph T., Mark Heipel, J. Bier, et al.. (2014). Arachidonic acid/cytochrome p450-derived mediators decrease hypoxic pulmonary vasoconstriction in isolated, ventilated and perfused mouse lungs. Pneumologie. 68(6). 1 indexed citations

Roth, M., Markus Rupp, Simone Hofmann, et al.. (2009). Heme Oxygenase-2 and Large-Conductance Ca2+-activated K+ Channels: Lung Vascular Effects of Hypoxia. American Journal of Respiratory and Critical Care Medicine. 180(4). 353–364. 35 indexed citations

Pfeil, Uwe, Muhammad Aslam, Renate Paddenberg, et al.. (2009). Intermedin/adrenomedullin-2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeability. American Journal of Physiology-Lung Cellular and Molecular Physiology. 297(5). L837–L845. 56 indexed citations

Keller, Stephan Sylvest, Robert Voswinckel, Karin Quanz, et al.. (2005). Congenital erythropoietin over-expression causes “anti-pulmonary hypertensive” structural and functional changes in mice, both in normoxia and hypoxia. Thrombosis and Haemostasis. 94(9). 630–638. 28 indexed citations

Weißmann, Norbert, Mahmut Ay, Karin Quanz, et al.. (2005). Impact of Mitochondria and NADPH Oxidases on Acute and Sustained Hypoxic Pulmonary Vasoconstriction. American Journal of Respiratory Cell and Molecular Biology. 34(4). 505–513. 74 indexed citations

Weißmann, Norbert, Karin Quanz, Ralph T. Schermuly, et al.. (2004). Basic features of hypoxic pulmonary vasoconstriction in mice. Respiratory Physiology & Neurobiology. 139(2). 191–202. 61 indexed citations

10.

Günther, Andreas, Monika Ermert, Ralph T. Schermuly, et al.. (2003). Prevention of Bleomycin-induced Lung Fibrosis by Aerosolization of Heparin or Urokinase in Rabbits. American Journal of Respiratory and Critical Care Medicine. 168(11). 1358–1365. 137 indexed citations

11.

Weißmann, Norbert, Hossein Ardeschir Ghofrani, Ralph T. Schermuly, et al.. (2003). Downregulation of hypoxic vasoconstriction by chronic hypoxia in rabbits: effects of nitric oxide. American Journal of Physiology-Heart and Circulatory Physiology. 284(3). H931–H938. 32 indexed citations

12.

Ghofrani, Hossein Ardeschir, R. Wiedemann, Frank Rose, et al.. (2002). Lung cGMP release subsequent to NO inhalation in pulmonary hypertension: respondersversusnonresponders. European Respiratory Journal. 19(4). 664–671. 20 indexed citations

13.

Wiedemann, R., Hossein Ardeschir Ghofrani, Norbert Weißmann, et al.. (2001). Atrial natriuretic peptide in severe primary and nonprimary pulmonary hypertension. Journal of the American College of Cardiology. 38(4). 1130–1136. 47 indexed citations

14.

Weißmann, Norbert, Robert Voswinckel, Karin Quanz, et al.. (2001). NO and reactive oxygen species are involved in biphasic hypoxic vasoconstriction of isolated rabbit lungs. American Journal of Physiology-Lung Cellular and Molecular Physiology. 280(4). L638–L645. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact